ArticleCureus2026
Anti-Ku Antibodies in a Patient With a Polymyositis-Systemic Sclerosis Overlap Syndrome in Association With Autoimmune Hepatitis.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Overlap syndromes are well-described but rare clinical entities characterized by the co-presence of two or more connective tissue diseases. The combination of systemic sclerosis and polymyositis overlapping with autoimmune hepatitis (AIH) is particularly rare, as discussed in this case report. A 76-year-old woman with a recent history of pleuro-pericarditis presented with painful Raynaud's phenomenon, lethargy, jaundice, myalgias, and weight loss. Blood tests revealed a positive antinuclear antibody and anti-Ku antibody and raised creatine kinase, together with evidence of myositis and interstitial lung disease on imaging, leading to a diagnosis of polymyositis-systemic sclerosis overlap syndrome. Raised liver transaminases, immunological tests, and liver biopsy were consistent with AIH. She was managed with corticosteroids and mycophenolate mofetil. This is only the second instance in which AIH has been reported in the context of a positive anti-Ku antibody. We discussed the complex and rare nature of this condition and the various aspects of its management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.